HearAtLast Holdings, Inc. Consolidated Financial Statements June 30 2022 (Amounts expressed in US Dollars)
Index
Consolidated Balance Sheets as at June 30 2022 (unaudited) and March 31, 2022 (unaudited)
Consolidated Statements of Operations and Comprehensive Loss for the 3‐month periods ended June 30, 2022 and June 30, 2021
Consolidated Statements of Changes in Stockholders' Deficiency for the period from March 31, 2017 to June 30, 2022
Consolidated Statements of Cash Flows for the 3‐month periods ended June 30, 2022 and June 30, 2021
Notes to Consolidated Financial Statements
……………………………
……………………………
……………………………
……………………………
……………………………
2
3
4
5
6 ‐ 12
TO THE STOCKHOLDERS OF HEARATLAST HOLDINGS INC.
The consolidated balance sheets of HearAtLast Holdings Inc. at June 30, 2022 and March 31, 2022 and the consolidated Statements of Operations and Comprehensive Loss, Changes in Stockholders' Deficiency and Cash Flows for the periods then ended have not been audited by the Company's auditors, Schwartz Levitsky Feldman LLP. These financial statements are the responsibility of management and have been reviewed and approved by the Company's audit committee and Board of Directors.
1
HearAtLast Holdings, Inc. Consolidated Balance Sheets
As at June 30, 2022 and March 31, 2022 (Amounts expressed in US Dollars)
2
HearAtLast Holdings, Inc.
Consolidated Statements of Operations and Comprehensive Loss For the 3‐month periods ended
June 30 2022 and June 30 2021 (Amounts Expressed in US Dollars)
3 Months Ended Jun 30 | |||||
2022 | 2021 | ||||
Revenue from sales of medical devices | $ | 4,098 | |||
Cost of sales | ‐ | ||||
Gross Profit | ‐ | 4,098 | |||
Expenses | |||||
Administration | 1,910 | 9,847 | |||
Consulting Fees | ‐ | 5,750 | |||
Total | 1,910 | 15,597 | |||
Net Loss | $ | (1,910) | $ | (11,499) | |
Interest on Notes Payable (note 6) | ‐ | 30,558 | |||
Write off of Investment | ‐ | ‐ | |||
Foreign exchange loss (gain) | (83) | ||||
Loss on debt conversion (note 7) | ‐ | 97,832 | |||
Comprehensive loss | $ | (1,910) | $ | (139,807) | |
Basic Loss per Share | |||||
Weighted Average Common Shares Outstanding | 297,661,157 | 212,165,907 | |||
Net Loss per Common Share, basic and diluted | $ | (0.000) | $ | (0.001) |
The accompanying notes are an integral part of these interim unaudited Consolidated Financial Statements
3
HearAtLast Holdings, Inc.
Consolidated Statements of Changes in Stockholders' Deficiency For the period from March 31, 2017 to June 30, 2022 (Amounts expressed in US Dollars)
Accumulated | |||||||||||||||||||
Quantity of | Other | ||||||||||||||||||
Quantity of common | Common | preferred | Preferred | Additional Paid‐ | Comprehensive | Stockholders' | |||||||||||||
shares | shares ($) | shares | shares ($) | in Capital | Loss | Deficit | Deficiency | ||||||||||||
Balance March 31, 2017 (unaudited) | 1,000,066 | 1,000 | 1,530,856 | 1,530 | 12,548,478 | (1,318,370) | (12,666,040) | (1,433,402) | |||||||||||
Net Income | ‐ | ||||||||||||||||||
Balance March 31, 2018 (unaudited) | 1,000,066 | 1,000 | 1,530,856 | 1,530 | 12,548,478 | (1,318,370) | (12,666,040) | (1,433,402) | |||||||||||
Shares issued to purchase Future Sonic | 25,000,000 | 25,000 | (24,900) | 100 | |||||||||||||||
Net loss | (3,000) | (3,000) | |||||||||||||||||
Balance March 31, 2019 (unaudited) | 26,000,066 | 26,000 | 1,530,856 | 1,530 | 12,523,578 | (1,318,370) | (12,669,040) | (1,436,302) | |||||||||||
Return of shares from Future Sonic | (25,000,000) | (25,000) | 24,900 | (100) | |||||||||||||||
Conversion of debt to common shares | 8,131,000 | 8,131 | 298,619 | 306,750 | |||||||||||||||
Net loss | (1,628,524) | (1,628,524) | |||||||||||||||||
Balance March 31 2020 (unaudited) | 9,131,066 | 9,131 | 1,530,856 | 1,530 | 12,847,097 | (1,318,370) | (14,297,564) | (2,758,176) | |||||||||||
Conversion of debt to common shares | 174,269,075 | 174,269 | 1,677,816 | 1,852,085 | |||||||||||||||
Shares issued to purchase Crystal Clear | 20,000,000 | 20,000 | 208,000 | 228,000 | |||||||||||||||
Net loss | (1,814,500) | (1,814,500) | |||||||||||||||||
Balance March 31 2021 (unaudited) | 203,400,141 | 203,400 | 1,530,856 | 1,530 | 14,732,913 | (1,318,370) | (16,112,064) | (2,492,592) | |||||||||||
Conversion of debt to common shares | 94,261,016 | 94,261 | 299,437 | 393,698 | |||||||||||||||
Net loss | (765,950) | (765,950) | |||||||||||||||||
Balance March 31 2022 (unaudited) | 297,661,157 | 297,661 | 1,530,856 | 1,530 | 15,032,350 | (1,318,370) | (16,878,014) | (2,864,844) | |||||||||||
Net loss | (1,910) | (1,910) | |||||||||||||||||
Balance June 30 2022 (unaudited) | 297,661,157 | 297,661 | 1,530,856 | 1,530 | 15,032,350 | (1,318,370) | (16,879,924) | (2,866,755) |
The accompanying notes are an integral part of these unaudited Consolidated Financial Statements
4
This is an excerpt of the original content. To continue reading it, access the original document here.
Attachments
- Original Link
- Original Document
- Permalink
Disclaimer
Hear Atlast Holdings Inc. published this content on 19 August 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 19 August 2022 17:13:16 UTC.